Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MELANOMA PATIENTS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 191 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. van Diest, PJ; Torrenga, H; Meijer, S; Meijer, CJLM
      Pathologic analysis of sentinel lymph nodes

      SEMINARS IN SURGICAL ONCOLOGY
    2. Pittet, MJ; Speiser, DE; Valmori, D; Rimoldi, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients

      INTERNATIONAL IMMUNOPHARMACOLOGY
    3. Kim, YJ; Broxmeyer, HE
      Therapeutic potential of 4-1BB (CD137) as a regulator for effector CD8(+) T cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    4. Garderet, L; Cao, H; Salamero, J; Verge, V; Tisserand, E; Scholl, S; Gorin, NC; Lopez, M
      In vitro production of dendritic cells from human blood monocytes for therapeutic use

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    5. Tanigawa, K; Takeshita, N; Eickhoff, GA; Shimizu, K; Chang, AE
      Antitumor reactivity of lymph node cells primed in vivo with dendritic cell-based vaccines

      JOURNAL OF IMMUNOTHERAPY
    6. Kim, YJ; Gin, DY
      Synthesis of the trisaccharide portion of the immunologic adjuvant QS-21A via sulfonium-mediated oxidative and dehydrative glycosylation

      ORGANIC LETTERS
    7. Man, S; Fiander, A
      Immunology of human papillomavirus infection in lower genital tract neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    8. Holmberg, LA; Sandmaier, BM
      Theratope((R)) vaccine (STn-KLH)

      EXPERT OPINION ON BIOLOGICAL THERAPY
    9. Nestle, FO; Banchereau, J; Hart, D
      Dendritic cells: On the move from bench to bedside

      NATURE MEDICINE
    10. Feuerer, M; Beckhove, P; Bai, LH; Solomayer, EF; Bastert, G; Diel, IJ; Pedain, C; Oberniedermayr, M; Schirrmacher, V; Umansky, V
      Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow

      NATURE MEDICINE
    11. Foon, KA; Bhattacharya-Chatterjee, M
      Are solid tumor anti-idiotype vaccines ready for prime time? Commentary re: U. Wagner et al., immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: Immune responses and survival in palliative treatment. Clin. Cancer Res., 7 : 1154-1162, 2001.

      CLINICAL CANCER RESEARCH
    12. Romero, P; Dutoit, V; Rubio-Godoy, V; Lienard, D; Speiser, D; Guillaume, P; Servis, K; Rimoldi, D; Cerottini, JC; Valmori, D
      CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences

      CLINICAL CANCER RESEARCH
    13. Rudolf, MP; Man, S; Melief, CJM; Sette, A; Kast, WM
      Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7

      CLINICAL CANCER RESEARCH
    14. Pittet, MJ; Speiser, DE; Lienard, D; Valmori, D; Guillaume, P; Dutoit, V; Rimoldi, D; Lejeune, F; Cerottini, JC; Romero, P
      Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide

      CLINICAL CANCER RESEARCH
    15. Taheri, F; Ochoa, JB; Faghiri, Z; Culotta, K; Park, HJ; Lan, MS; Zea, AH; Ochoa, AC
      L-arginine regulates the expression of the T-cell receptor zeta chain (CD3zeta) in Jurkat cells

      CLINICAL CANCER RESEARCH
    16. Vonderheide, RH; Anderson, KS; Hahn, WC; Butler, MO; Schultze, JL; Nadler, LM
      Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase

      CLINICAL CANCER RESEARCH
    17. Maki, RG
      Soft tissue sarcoma as a model disease to examine cancer immunotherapy

      CURRENT OPINION IN ONCOLOGY
    18. Gunzer, M; Grabbe, S
      Dendritic cells in cancer immunotherapy

      CRITICAL REVIEWS IN IMMUNOLOGY
    19. Czerniecki, BJ; Cohen, PA; Faries, M; Xu, SW; Roros, JG; Bedrosian, I
      Diverse functional activity of CD83(+) monocyte-derived dendritic cells and the implications for cancer vaccines

      CRITICAL REVIEWS IN IMMUNOLOGY
    20. Lauerova, L; Dusek, L; Spurny, V; Simickova, M; Rovny, A; Rejthar, A; Kocak, I; Kovarik, J
      Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients

      ONCOLOGY REPORTS
    21. Yee, C; Riddell, SR; Greenberg, PD
      In vivo tracking of tumor-specific T cells

      CURRENT OPINION IN IMMUNOLOGY
    22. Renner, C; Kubuschok, B; Trumper, L; Pfreundschuh, M
      Clinical approaches to vaccination in oncology

      ANNALS OF HEMATOLOGY
    23. Sondel, PM; Hank, JA
      Antibody-directed, effector cell-mediated tumor destruction

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    24. Yashiki, S; Fujiyoshi, T; Arima, N; Osame, M; Yoshinaga, M; Nagata, Y; Tara, M; Nomura, K; Utsunomiya, A; Hanada, S; Tajima, K; Sonoda, S
      HLA-A*26, HLA-B*4002, HLA-B*4006, and HLA-B*4801 alleles predispose to adult T cell leukemia: The limited recognition of HTLV type 1 tax peptide anchor motifs and epitopes to generate anti-HTLV type 1 tax CD8(+) cytotoxic T lymphocytes

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    25. Toungouz, M; Libin, M; Bulte, F; Faid, L; Lehmann, F; Duriau, D; Laporte, M; Gangji, D; Bruyns, C; Lambermont, M; Goldman, M; Velu, T
      Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors

      JOURNAL OF LEUKOCYTE BIOLOGY
    26. Takayanagi, T; Ohuchi, A
      A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes

      MICROBIOLOGY AND IMMUNOLOGY
    27. Melichar, B; Touskova, M; Tosner, J; Kopecky, O
      The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries

      ONKOLOGIE
    28. Stone, B; Schummer, M; Paley, PJ; Crawford, M; Ford, M; Urban, N; Nelson, BH
      MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily

      GENE
    29. Blocklet, D; Donckier, V; Vereecken, P; Van Geertruyden, J; Laporte, M; Goldman, S
      Lymphoscintigraphy as a result of massive malignant invasion shown by positron emission tomography

      CLINICAL NUCLEAR MEDICINE
    30. Yoshida, S; Morii, K; Watanabe, M; Saito, T; Yamamoto, K; Tanaka, R
      The generation of anti-tumoral cells using dendritic cells from the peripheral blood of patients with malignant brain tumors

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    31. Chen, CH; Chen, CJ; Lee, HS; Huang, GT; Yang, PM; Tsai, LJ; Chen, DS; Sheu, JC
      Expressions of cancer-testis antigens in human hepatocellular carcinomas

      CANCER LETTERS
    32. Schott, M; Feldkamp, J; Lettmann, M; Simon, D; Scherbaum, WA; Seissler, J
      Dendritic cell immunotherapy in a neuroendocrine pancreas carcinoma

      CLINICAL ENDOCRINOLOGY
    33. Waite, DC; Jacobson, EW; Ennis, FA; Edelman, R; White, B; Kammer, R; Anderson, C; Kensil, CR
      Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21

      VACCINE
    34. Schultze, JL; Maecker, B; von Bergwelt-Baildon, MS; Anderson, KS; Vongerheide, RH
      Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens

      VOX SANGUINIS
    35. Bleesing, JJH; Fleisher, TA
      Cell function-based flow cytometry

      SEMINARS IN HEMATOLOGY
    36. Gilewski, T; Ragupathi, G; Bhuta, S; Williams, LJ; Musselli, C; Zhang, XF; Bencsath, KP; Panageas, KS; Chin, J; Hudis, CA; Norton, L; Houghton, AN; Livingston, PO; Danishefsky, SJ
      Immunization of metastatic breast cancer patients with a fully synthetic globe H conjugate: A phase I trial

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    37. Rubio-Godoy, V; Dutoit, V; Rimoldi, D; Lienard, D; Lejeune, F; Speiser, D; Guillaume, P; Cerottini, JC; Romero, P; Valmori, D
      Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    38. Riddell, SR
      Progress in cancer vaccines by enhanced self-presentation

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    39. Galetto, A; Contarini, M; Sapino, A; Cassoni, P; Consalvo, E; Forno, S; Pezzi, C; Barnaba, V; Mussa, A; Matera, L
      Ex vivo host response to gastrointestinal cancer cells presented by autologous dendritic cells

      JOURNAL OF SURGICAL RESEARCH
    40. Palermo, B; Campanelli, R; Garbelli, S; Mantovani, S; Lantelme, E; Brazzelli, V; Ardigo, M; Borroni, G; Martinetti, M; Badulli, C; Necker, A; Giachino, C
      Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo

      JOURNAL OF INVESTIGATIVE DERMATOLOGY
    41. Speiser, DE; Colonna, M; Ayyoub, M; Cella, M; Pittet, MJ; Batard, P; Valmori, D; Guillaume, P; Lienard, D; Cerottini, JC; Romero, P
      The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells

      JOURNAL OF IMMUNOLOGY
    42. Denkberg, G; Cohen, CJ; Reiter, Y
      Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-Peptide tetramers to TCR

      JOURNAL OF IMMUNOLOGY
    43. Bonini, C; Lee, SP; Riddell, SR; Greenberg, PD
      Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4(+) and CD8(+) T cells

      JOURNAL OF IMMUNOLOGY
    44. Hernandez, J; Ko, A; Sherman, LA
      CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen

      JOURNAL OF IMMUNOLOGY
    45. Pittet, MJ; Zippelius, A; Speiser, DE; Assenmacher, M; Guillaume, P; Valmori, D; Lienard, D; Lejeune, F; Cerottini, JC; Romero, P
      Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases

      JOURNAL OF IMMUNOLOGY
    46. Wei, WZ; Ratner, S; Shibuya, T; Yoo, G; Jani, A
      Foreign antigenic peptides delivered to the tumor as targets of cytotoxic T cells

      JOURNAL OF IMMUNOLOGICAL METHODS
    47. Schmittel, A; Keilholz, U; Bauer, S; Kuhne, U; Stevanovic, S; Thiel, E; Scheibenbogen, C
      Application of the IFN-gamma ELISPOT assay to quantify T cell responses against proteins

      JOURNAL OF IMMUNOLOGICAL METHODS
    48. Schott, M; Seissler, J; Lettmann, M; Fouxon, V; Scherbaum, WA; Feldkamp, J
      Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    49. Kampgen, E; Becker, J; Brocker, EB
      Cell therapy with dendritic cells

      INTERNIST
    50. Lally, KM; Mocellin, S; Ohnmacht, GA; Nielsen, MB; Bettinotti, M; Panelli, MC; Monsurro, V; Marincola, FM
      Unmasking cryptic epitopes after loss of immunodominant tumor antigen expression through epitope spreading

      INTERNATIONAL JOURNAL OF CANCER
    51. Kurokawa, T; Oelke, M; Mackensen, A
      Induction and clonal expansion of tumor-specific cytotoxic T lymphocytes from renal cell carcinoma patients after stimulation with autologous dendritic cells loaded with tumor cells

      INTERNATIONAL JOURNAL OF CANCER
    52. Cefai, D; Favre, L; Wattendorf, E; Marti, A; Jaggi, R; Gimmi, CD
      Role of Fas ligand expression in promoting escape from immune rejection ina spontaneous tumor model

      INTERNATIONAL JOURNAL OF CANCER
    53. Nishioka, Y; Nishimura, N; Suzuki, Y; Sone, S
      Human monocyte-derived and CD83(+) blood dendritic cells enhance NK cell-mediated cytotoxicity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    54. Mathiassen, S; Lauemoller, SL; Ruhwald, M; Claesson, MH; Buus, S
      Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

      EUROPEAN JOURNAL OF IMMUNOLOGY
    55. Miyashiro, I; Kuo, C; Huynh, K; Iida, A; Morton, D; Bilchik, A; Giuliano, A; Hoon, DSB
      Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes

      CLINICAL CHEMISTRY
    56. Karanikas, V; Colau, D; Baurain, JF; Chiari, R; Thonnard, J; Gutierrez-Roelens, I; Goffinet, C; Van Schaftingen, E; Weynants, P; Boon, T; Coulie, PG
      High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival

      CANCER RESEARCH
    57. Yu, JS; Wheeler, CJ; Zeltzer, PM; Ying, H; Finger, DN; Lee, PK; Yong, WH; Incardona, F; Thompson, RC; Riedinger, MS; Zhang, WX; Prins, RM; Black, KL
      Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

      CANCER RESEARCH
    58. Geiger, JD; Hutchinson, RJ; Hohenkirk, LF; McKenna, EA; Yanik, GA; Levine, JE; Chang, AE; Braun, TM; Mule, JJ
      Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression

      CANCER RESEARCH
    59. Yamada, A; Kawano, K; Koga, M; Matsumoto, T; Itoh, K
      Multidrug resistance-associated protein 3 is a tumor rejection antigen recognized by HLA-A2402-restricted cytotoxic T lymphocytes

      CANCER RESEARCH
    60. Kobayashi, H; Song, YS; Hoon, DSB; Appella, E; Celis, E
      Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles

      CANCER RESEARCH
    61. Shoaib, T; Soutar, DS; MacDonald, DG; Camilleri, IG; Dunaway, DJ; Gray, HW; McCurrach, GM; Bessent, RG; MacLeod, TIF; Robertson, AG
      The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically NO neck

      CANCER
    62. Chouaib, S; Echchakir, H; Angevin, E; Guerra, N; Kosmatopoulos, K; Caignard, A; Lim, A; Baron, V; Ferradini, L; Mami-Chouaib, F
      Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring

      BULLETIN DU CANCER
    63. Schleiermacher, G; Delattre, O
      Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours

      BULLETIN DU CANCER
    64. Allan, R
      Sentinel node localization: do or dye alone?

      BRITISH JOURNAL OF RADIOLOGY
    65. Coronel, A; Boyer, A; Franssen, JD; Romet-Lemonne, JL; Fridman, WH; Teillaud, JL
      Cytokine production and T-cell activation by macrophage-dendritic cells generated for therapeutic use

      BRITISH JOURNAL OF HAEMATOLOGY
    66. Muller, L; Provenzani, C; Faul, C; Pawelec, G
      Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's dendritic cells

      BRITISH JOURNAL OF HAEMATOLOGY
    67. Wascher, RA; Bostick, PJ; Huynh, KT; Turner, R; Qi, K; Giuliano, AE; Hoon, DSB
      Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes

      BRITISH JOURNAL OF CANCER
    68. Umano, Y; Tsunoda, T; Tanaka, H; Matsuda, K; Yamaue, H; Tanimura, H
      Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53

      BRITISH JOURNAL OF CANCER
    69. Sollner, W; DeVries, A; Steixner, E; Lukas, P; Sprinzl, G; Rumpold, G; Maislinger, S
      How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?

      BRITISH JOURNAL OF CANCER
    70. Taylor, DD; Bender, DP; Gercel-Taylor, C; Stanson, J; Whiteside, T
      Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients

      BRITISH JOURNAL OF CANCER
    71. Shinitzky, M; Goldman, Y
      Immunotherapy of cancer with pressure modified cells

      ISRAEL MEDICAL ASSOCIATION JOURNAL
    72. Schmittel, A; Keilholz, U; Thiel, E; Scheibenbogen, C
      Quantification of tumor-specific T lymphocytes with the ELISPOT assay

      JOURNAL OF IMMUNOTHERAPY
    73. Inoue, Y; Nakao, M; Matsunaga, K; Kikuchi, M; Gomi, S; Toh, U; Takamori, S; Yamana, H; Itoh, K
      Induction of human leukocyte antigen-A26-restricted and tumor-specific cytotoxic T lymphocytes by a single peptide of the SART1 antigen in patients with cancer with different A26 subtypes

      JOURNAL OF IMMUNOTHERAPY
    74. Bedrosian, I; Roros, JG; Xu, SW; Nguyen, HQ; Engels, F; Faries, MB; Koski, GK; Cohen, PA; Czerniecki, BJ
      Granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-12 synergize with calcium ionophore to enhance dendritic cell function

      JOURNAL OF IMMUNOTHERAPY
    75. Carmon, L; Tzehoval, E; Tirosh, B; el-Shami, KM; Bar-Haim, E; Vadai, E; Feldman, M; Eisenbach, L
      Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles

      JOURNAL OF IMMUNOTHERAPY
    76. Ressing, ME; van Driel, WJ; Brandt, RMP; Kenter, GG; de Jong, JH; Bauknecht, T; Fleuren, GJ; Hoogerhout, P; Offringa, R; Sette, A; Celis, E; Grey, H; Trimbos, BJ; Kast, WM; Melief, CJM
      Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma

      JOURNAL OF IMMUNOTHERAPY
    77. Serrano, D; Becker, K; Cunningham-Rundles, C; Mayer, L
      Characterization of the T cell receptor repertoire in patients with commonvariable immunodeficiency: Oligoclonal expansion of CD8(+) T cells

      CLINICAL IMMUNOLOGY
    78. Danishefsky, SJ; Allen, JR
      From the laboratory to the clinic: A retrospective on fully synthetic carbohydrate-based anticancer vaccines

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

    79. The anti-idiotypic antibody 4B5 (mimicking ganglioside GD2) for diagnosis and therapy of cancer

      EXPERT OPINION ON THERAPEUTIC PATENTS
    80. Greenberg, PD; Yee, C; Warren, EH; Gavin, M; Topp, M; Cooper, L; Nelson, B; Ohlen, C; Riddell, SR
      Therapy of human viral and malignant diseases with gene-modified T cell clones

      EUROPEAN CYTOKINE NETWORK
    81. Irvine, AS; Trinder, PKE; Laughton, DL; Ketteringham, H; McDermott, RH; Reid, SCH; Haines, AMR; Amir, A; Husain, R; Doshi, R; Young, LS; Mountain, A
      Efficient nonviral transfection of dendritic cells and their use for in vivo immunization

      NATURE BIOTECHNOLOGY
    82. Cheung, NKV; Guo, HF; Heller, G; Cheung, IY
      Induction of Ab3 and Ab3 ' antibody was associated with long-term survivalafter anti-G(D2) antibody therapy of stage 4 neuroblastoma

      CLINICAL CANCER RESEARCH
    83. Karanikas, V; Lodding, J; Maino, VC; McKenzie, IFC
      Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy

      CLINICAL CANCER RESEARCH
    84. Chapman, PB; Morrisey, D; Panageas, KS; Williams, L; Lewis, JJ; Israel, RJ; Hamilton, WB; Livingston, PO
      Vaccination with a bivalent G(M2) and G(D2) ganglioside conjugate vaccine:A trial comparing doses of G(D2)-keyhole limpet hemocyanin

      CLINICAL CANCER RESEARCH
    85. Anderson, BW; Peoples, GE; Murray, JL; Gillogly, MA; Gershenson, DM; Ioannides, CG
      Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals

      CLINICAL CANCER RESEARCH
    86. Whiteside, TL
      Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    87. Asai, T; Storkus, WJ; Whiteside, TL
      Evaluation of the modified ELISPOT assay for gamma interferon production in cancer patients receiving antitumor vaccines

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    88. Jiang, XP; Yang, DC; Elliott, RL; Head, JF
      Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status

      CYTOKINE
    89. Vazquez, AM; Gabri, MR; Hernandez, AM; Alonso, DF; Beausoleil, I; Gomez, DE; Perez, R
      Antitumor properties of an anti-idiotypic monoclonal antibody in relation to N-glycolyl-containing gangliosides

      ONCOLOGY REPORTS
    90. Strobel, I; Berchtold, S; Gotze, A; Schulze, U; Schuler, G; Steinkasserer, A
      Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes

      GENE THERAPY
    91. Hanibuchi, M; Nishioka, Y; Yanagawa, H; Yano, S; Parajuli, P; Bando, M; Sone, S
      Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity

      ONCOLOGY RESEARCH
    92. Allen, JR; Allen, JG; Zhang, XF; Williams, LJ; Zatorski, A; Ragupathi, G; Livingston, PO; Danishefsky, SJ
      A second generation synthesis of the MBr1 (Globo-H) breast tumor antigen: New application of the n-pentenyl glycoside method for achieving complex carbohydrate protein linkages

      CHEMISTRY-A EUROPEAN JOURNAL
    93. Renner, C; Trumper, L; Pfreundschuh, M
      Tumour vaccines: a new immunotherapeutic approach in oncology

      ANNALS OF HEMATOLOGY
    94. Okada, H; Attanucci, J; Tahara, H; Pollack, IF; Bozik, ME; Chambers, WH; Lotze, MT
      Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy

      CANCER GENE THERAPY
    95. Goxe, B; Latour, N; Chokri, M; Abastado, JP; Salcedo, M
      Simplified method to generate large quantities of dendritic cells suitablefor clinical applications

      IMMUNOLOGICAL INVESTIGATIONS
    96. Hanai, N; Nakamura, K; Shitara, K
      Recombinant antibodies against ganglioside expressed on tumor cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    97. Anderson, RW; Kudelka, AP; Honda, T; Pollack, MS; Gershenson, DM; Gillogly, MA; Murray, JL; Ioannides, CG
      Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    98. Perico, ME; Mezzanzanica, D; Luison, E; Alberti, P; Panza, L; Russo, G; Canevari, S
      Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    99. Mackensen, A; Drager, R; Schlesier, M; Mertelsmann, R; Lindemann, A
      Presence of IgE antibodies to bovine serum albumin in a patient developinganaphylaxis after vaccination with human peptide-pulsed dendritic cells

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    100. Arlen, P; Tsang, KY; Marshall, JL; Chen, A; Steinberg, SM; Poole, D; Hand, PH; Schlom, J; Hamilton, JM
      The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines

      CANCER IMMUNOLOGY IMMUNOTHERAPY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 05:12:57